comparemela.com

Latest Breaking News On - Point nine capital - Page 4 : comparemela.com

Gourmey grabs $48 million to keep working on lab-grown foie gras

Gourmey is part of a new wave of companies that want to turn cell-cultured meat products into mainstream products.

Nicolas morinEarlybird ventureKeen venture partnersOmnes capitalThia venturesHeartcore capitalPoint nine capitalAir street capitalStanding ovation

Technology industry artificial intelligence venture financing deals in Europe

Top five technology industry artificial intelligence venture financing deals in Europe in August 2022, according to GlobalData

United kingdomFrederic kerrestMax mullenJavier molinarKleiner perkinsAndrew ofstadAvlok kohliJeremy stoppemanAkshay kothariAneel bhusriTaylor brownJames tamplinAaron levieHowie liuJeff lawsonNeha narkhede

Mavenoid Raises $30m to Bring AI-Powered Product Support to Hardware Brands

Mavenoid takes aim at the high cost required for technical product support by providing AI-powered automation and remote support tools Mavenoid, the leading hardware support platform, today announced

United kingdomStaffan helgessonKostenloser wertpapierhandelPeter duffyShahan liljaLeah jonesTechnology venturesPoint nine capitalGeneral partner

Mavenoid raises $30m to bring AI-powered product support to hardware brands

Mavenoid’s platform takes aim at the high cost required for technical product support by providing AI-powered automation and remote support tools STOCKHOLM, August 31, 2022 — Mavenoid, the leading hardware support platform, today announced that it has secured $30 million in a Series B financing round led by Smedvig Capital.

United kingdomStaffan helgessonPeter duffyShahan liljaTechnology venturesPoint nine capitalSmedvig capitalGeneral partner

Mavenoid Raises $30M in Series B Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United kingdomShahan liljaTechnology venturesSmedvig capitalPoint nine capital

vimarsana © 2020. All Rights Reserved.